These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 338631)

  • 41. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
    Rabinowe SL; Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T; Oseko F; Ikeda F; Nanno M; Endo J
    J Clin Endocrinol Metab; 1976 Oct; 43(4):940-3. PubMed ID: 977730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence that des-Asp1 angiotensin II mediates the renin-angiotensin response.
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Circ Res; 1976 Jun; 38(6 Suppl 2):99-103. PubMed ID: 178468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH; Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
    Williams GH; Hollenberg NK; Brown C; Mersey JH
    J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Nanno M; Imura H; Endo J
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):359-66. PubMed ID: 580136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of aldosterone response to furosemide test in patients with Shy-Drager syndrome.
    Sasaki K; Murabayashi S; Baba T; Aoyagi K; Matsunaga M; Takebe K; Nigawara K
    Horm Metab Res; 1983 Dec; 15(12):610-5. PubMed ID: 6363244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake.
    Cowley AW; McCaa RE
    Circ Res; 1976 Dec; 39(6):788-97. PubMed ID: 1000772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of aldosterone and blood pressure to angiotensin II infusion in anephric man. Effect of sodium deprivation.
    Deheneffe J; Cuesta V; Briggs JD; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson IS; Tree M
    Circ Res; 1976 Aug; 39(2):183-90. PubMed ID: 939003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological activity of des-Asp1-angiotensin I in man.
    Kono T; Ikeda F; Oseko F; Imura H; Endo J
    J Clin Endocrinol Metab; 1980 Jan; 50(1):40-5. PubMed ID: 7350186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renin-angiotensin-aldosterone system of the normothermic marmot.
    Kastner PR; Zatzman ML; South FE; Johnson JA
    Am J Physiol; 1977 Jul; 233(1):R37-43. PubMed ID: 195479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of sodium balance and calcium channel-blocking drugs on plasma aldosterone responses to infusion of angiotensin II in normal subjects and patients with essential hypertension.
    Anderson GH; Howland T; Domschek R; Streeten DH
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1126-35. PubMed ID: 3760114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological activity of des-asp1-angiotensin II (angiotensin III) in man.
    Kono T; Oseko F; Shimpo S; Nanno M; Endo J
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1174-7. PubMed ID: 1206103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of prolonged infusions of angiotensin II on eight serum corticosteroids in man on different sodium diets.
    Schöneshöfer M; Oelkers W
    Horm Metab Res; 1980 Nov; 12(11):614-20. PubMed ID: 7193170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.
    Lely AT; Krikken JA; Bakker SJ; Boomsma F; Dullaart RP; Wolffenbuttel BH; Navis G
    J Clin Endocrinol Metab; 2007 May; 92(5):1821-6. PubMed ID: 17341566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.